As global tech supply chains realign and innovation becomes increasingly geopolitically strategic, Taiwan and the United States are formalizing a deeper, more structured startup alliance—this time with Phoenix, Arizona, at the center.
Startup Island TAIWAN, the national startup brand guided by Taiwan’s National Development Council (NDC), has signed a new Memorandum of Understanding (MOU) with the City of Phoenix, the Greater Phoenix Economic Council (GPEC), and Tesoro Venture Capital, in collaboration with Taiwan’s Industrial Technology Research Institute (ITRI). The agreement aims to accelerate co-development between Taiwanese and U.S. startup ecosystems across artificial intelligence, semiconductors, and advanced technologies.
The move builds directly on TSMC’s ongoing expansion in Phoenix, which has already transformed the region into one of the most strategically important semiconductor hubs in North America. But this MOU goes well beyond fabs and supply chains. It’s designed to institutionalize startup collaboration—turning ad hoc pilot projects into a long-term, scalable innovation pipeline.
From Ad Hoc Projects to a Standing Innovation Framework
The signing ceremony was jointly witnessed by Taiwan’s National Development Council, the Small and Medium Enterprise and Startup Administration (SMESA) under the Ministry of Economic Affairs, and the American Institute in Taiwan (AIT). That lineup matters. It signals that what began as project-based cooperation is now being elevated into a formal, government-backed collaboration framework.
Deputy Minister Jan Fang-Guan of the NDC emphasized that the agreement builds on two years of tangible results. Since Startup Island TAIWAN and GPEC first partnered in 2024, multiple Taiwanese biomedical startups have successfully entered the Phoenix market, achieving milestones that many early-stage companies struggle to reach in the U.S.—including FDA approvals and completed clinical proof-of-concept (POC) validations.
Those outcomes, Fang noted, demonstrate not just goodwill but real complementarity between Taiwan’s technology strengths and Phoenix’s industrial and clinical infrastructure. The new MOU expands that foundation by formally integrating incubators, accelerators, and venture capital partners—most notably Tesoro Venture Capital—into the collaboration.
The shift reflects a broader trend in global innovation policy: governments are no longer content to simply encourage startups to “network internationally.” Instead, they are building structured landing pads that reduce regulatory friction, speed up validation, and connect startups directly to customers, capital, and talent.
Why Phoenix—and Why Now?
Phoenix’s role in this partnership isn’t accidental. The city has rapidly evolved from a regional manufacturing center into a strategic node for semiconductors, AI, and advanced manufacturing. TSMC’s U.S. fabs have acted as a gravitational force, pulling in suppliers, design partners, and adjacent technology sectors.
At the same time, Phoenix offers something many coastal tech hubs no longer do: room to scale. Lower operating costs, a growing talent base, strong public–private coordination, and an increasingly international outlook have made it an attractive entry point for foreign startups—particularly those in regulated industries like healthcare and semiconductors.
Phoenix Mayor Kate Gallego highlighted this positioning directly, describing the city as both a semiconductor hub and an innovation gateway that integrates AI, talent, and capital. With direct flights between Taipei and Phoenix, access to institutions like the Mayo Clinic, and support from investors such as Tesoro Venture Capital, Gallego framed Phoenix as a pragmatic launchpad for Taiwanese startups entering the U.S. market.
Medical AI as Proof That the Model Works
If the partnership needed proof points, healthcare delivered them.
Phoenix’s status as one of the most retirement-friendly cities in the U.S. has made it a natural testbed for medical innovation. The presence of world-class institutions such as the Mayo Clinic creates a rare environment where clinical demand, regulatory pathways, and real-world deployment converge.
Several Taiwanese startups have already capitalized on this dynamic:
- JelloX leveraged its AI-powered 3D pathology imaging platform to collaborate with the Mayo Clinic, completing clinical validation and securing U.S. FDA clearance for colorectal polyp diagnosis.
- Brain Navi became one of the few Taiwanese teams to earn FDA approval for a robotic brain surgery system, underscoring Taiwan’s competitiveness in AI-driven medical automation.
- Aesop successfully completed U.S. clinical POC validation for its AI-based diagnostic reasoning model, demonstrating measurable improvements in clinical decision-making and workflow efficiency.
These cases illustrate why the Taiwan–Phoenix connection works. Taiwanese startups bring advanced AI and hardware capabilities; Phoenix provides clinical access, regulatory pathways, and real-world demand. The result is faster validation on both sides of the Pacific.
Semiconductors as the Anchor, Startups as the Multiplier
While healthcare has delivered early wins, semiconductors remain the strategic anchor of the partnership. Christine Mackay, President and CEO of GPEC, pointed out that since signing an earlier MOU with Startup Island TAIWAN in 2023, the two sides have already established a physical showcase site in Phoenix’s biomedical innovation district.
Through programs like SelectUSA, Taiwanese startups are being given structured, practical pathways into the U.S. market—supporting everything from direct sales to local hiring and regulatory navigation. The American Institute in Taiwan reaffirmed its commitment to this approach, noting its ongoing collaboration with GPEC to support not only startups but also TSMC supply-chain partners expanding into Arizona.
AIT also highlighted Taiwan’s breadth of strengths, from AI and healthcare to manufacturing, drones, aerospace, and defense—sectors that increasingly overlap as technologies converge.
SMEs at the Core of the Strategy
Despite the involvement of major institutions and global players, the collaboration remains explicitly focused on small and medium-sized enterprises.
SMESA Director General Kuan-Chih Lee emphasized that SMEs will continue to serve as the backbone of the initiative. By integrating Taiwan’s talent, technology, and startup communities, SMESA aims to help companies participate in SelectUSA and build scalable industrial clusters in Phoenix and across Arizona.
This SME-centric approach reflects Taiwan’s broader economic model, where small and mid-sized firms play outsized roles in global supply chains. The goal isn’t just to help individual startups succeed, but to create dense, resilient clusters that can support long-term industrial cooperation between Taiwan and the U.S.
Tesoro Venture Capital’s Five-Year Bet
For Tesoro Venture Capital, the MOU represents a long-term investment thesis rather than a short-term deal flow play.
Founder Andy Lombard stated that Tesoro plans to cultivate 200 to 300 startups over the next five years, with a focus on AI and semiconductors. Crucially, Lombard emphasized alignment—between industry leaders like TSMC, Cadence, and Amkor, and consistent government policy support on both sides of the Pacific.
To ensure execution, Lombard proposed forming an executive committee made up of leaders from the signatory organizations. The committee would set measurable goals, oversee progress, and focus heavily on talent and workforce development—often the limiting factor in cross-border expansion.
In other words, this MOU isn’t meant to sit on a shelf. It’s designed to function as a governance mechanism for real acceleration.
Toward Measurable, Replicable Outcomes
Looking ahead, the partnership will focus on AI, semiconductors, advanced manufacturing, photonics, AI-driven healthcare, and defense-related industries. The intent is bilateral: supporting Taiwanese startups entering the U.S. market while also attracting U.S. teams to collaborate with Taiwan’s research institutes, manufacturers, and innovation hubs.
As Phoenix continues to grow into a cornerstone of America’s advanced technology strategy—and as Taiwan remains indispensable to global semiconductor and AI ecosystems—this collaboration aims to turn geopolitical alignment into economic output.
The real test will be execution: startups launched, products validated, jobs created, and capital deployed. But if the early healthcare successes are any indication, the Taiwan–Phoenix model may offer a blueprint for how cross-border innovation partnerships evolve in a more fragmented, strategically conscious tech world.
For now, the message is clear. Taiwan and Phoenix aren’t just cooperating—they’re building an institutional bridge designed to move technology, talent, and startups at scale.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
